Strength
3 mg/1
Manufacturer
Sebela Pharmaceuticals Inc.NDC
54766009306
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
12/17/2025
Active Ingredients
AURANOFINApproval Type
New Drug (NDA)
FDA Application
NDA018689On Market Since
12/15/2016
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.